Cellebrite DI Ltd. (CLBT) reports 653 RSUs vested; affiliate sold shares

Rhea-AI Filing Summary

Cellebrite DI Ltd. submitted a Form 144 notice reporting proposed sales of ordinary shares and related transactions. The filing lists 653 Restricted Share Units vested under an issuer S-8 registered plan on 05/11/2026 and shows recent sales by an affiliate, David Gee, of 1,165, 2,609, and 4,517 ordinary shares on 02/12/2026, 02/23/2026, and 02/24/2026, respectively.

Insights

Securities Counsel

Form 144 lists proposed resale activity and recent affiliate sales.

The notice records vested Restricted Share Units (653) under an S-8 plan and identifies recent dispositions by David Gee of 1,165, 2,609, and 4,517 shares on the dates shown. The filing functions as a compliance disclosure under resale rules.

Timing and volume are documented here; cash‑flow treatment and whether the 653 vested units are being sold under Rule 144 are not stated in the excerpt. Subsequent filings or broker confirmations would show execution details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	228	2975.40	249746054	05/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	05/11/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	Cellebrite DI Ltd.			653	05/11/2026	Employee compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Gee 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/12/2026	1165	15848.68
David Gee 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/23/2026	2609	32514.59
David Gee 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/24/2026	4517	53932.98

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)